Commercialization: Page 119
-
PharmaVoice Team/PharmaVoice
E-Media
E-Media New electronic and web-based applications, sites, and technologies NoInk Communications has released Pharma-SalesAccelerator, a new suite of applications specifically designed to improve productivity and increase performance of pharmaceutical sales organizations. NoInk partnered with Pedi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Eileen M. Lach Wyeth Fills VP, Associate General Counsel Position Wyeth has promoted Eileen M. Lach to the position of VP, corporate secretary, and associate general counsel. Wyeth, Madison, N.J., is a pharma...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
May 2004 The forum for the industry executive Narrowing the GAP Between R&D and Marketing Building Strategic Teams with Marsha Fanucci Trial Coordinators The Front Line Building Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
What’s on Your Mind — Opinions More on the New DTC Guidelines PharmaVOICE received an overwhelming number of responses to our January opinion question, which addressed the FDA proposed changes to the regulations that govern the content and format of the product disclaimer or brief summary that mu...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
-
PharmaVoice Team/PharmaVoice
Letter from the Editor
Early-stage commercial spending can top $60 million for blockbuster products, according to Cutting Edge Information. With such high commercial investments come equally elevated risks that drugs will fail to reach the market or achieve less than their full commercial potential. It is critical that...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
on the cover Getting into the details of e-detailing E-detailing is slowly becoming an accepted medium for bringing new information to physicians. It holds the promise of building better relationships with prescribers and other healthcare practitioners. 8 FEATURES Connecting with the community Th...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
According to Manhattan Research, 2004 will be the pivotal year for the future of pharmaceutical e-detailing programs. Pharmaceutical companies are finding that although the cost of detailing products to physicians is rising, tangible results are not. E-detailing can strengthen the pharmaceutical-...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
PharmaVOICE The forum for the industry executive June 2004 integrating e-detailing Into the Overall Strategy contract Manufacturing with Darlene Ryan marketing High-Science Products www.pharmavoice.com Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaCase
Making a case for getting the brand name right What’s in a Name? A new brand name must inherently – through the image it conveys, the way it sounds, and the way it rolls off someone’s tongue – describe the essence of the brand and the advantages that a user would enjoy. Think of how simply and po...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by David Kerr Too Much Material, Too Little Time With market share, revenue goals, and stock prices riding on the success of every new product launch, pharmaceutical companies invest substantial resources to equip their mobile sales teams with the information, training, tools, and sup...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. – in combination or as single brand...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
What’s on your Mind Opinions 24/7/365 – What Keeps You Going? Putting in the time is no longer an option. Work days are longer; work weeks extend into weekends; and months roll by as the pages fly off the calendar. PharmaVOICE wanted to know what keeps you motivated in this 24/7/365 environment. ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s new New healthcare-related products, services, and companies Ventiv Health expands Services Ventiv Health has launched Ventiv Recruitment Services as a stand-alone option to provide clients with targeted, highly effective sales professionals across many therapeutic areas. “Specialty pharma...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
E-Media New electronic and web-based applications, sites, and technologies Model N Introduces Revenue-Management Software Model N Inc. has developed a pharmaceutical-specific suite of applications to manage pricing, contracts, and payment of settlements. The Model N Revenue Management Suite, comp...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Publication Planning: The Science Behind it All
Publication planning The Science Behind It All by Elisabeth Pena Scientific publications are the foundation on which a drug’s identity is created, serving a vital role for all marketing and communications efforts behind the brand. The publication plan for a pharmaceutical product is one of the mo...
By Elisabeth Pena • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma trax Sales, marketing, And R&D Trends affecting the healthcare industry The Changing Pharma Market Demographic trends present an opportunity for drug companies to target a growing patient pool with a growing demand for therapeutics across various diseases. This is one of the conclusion...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
A More Complete View of the Patient
A More Complete View of the Patient A new approach that moves beyond physician prescribing data and promotional share-of-voice battles is needed to sustain growth. That new approach is anonymous patient-centric data, which is derived from claims data and tracks a patient across the entire continu...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Contents on the cover Managing outcomes Limits on reimbursement for prescription drugs are expected to have a long-term impact on drug development. To address payer concerns, companies will need to have data on cost versus utility, and those data come from outcomes studies. But to use effectively...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
Cover Featured on the Cover Outcomes Data: Assessing the Total Value of a Drug Delivering on the Commitment with Arthur Higgins CME Going Forward July 2004 Volume 4 Number 7 The Forum for the Industry Executive Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Raise your Voice Letters Information for Real-World Value Messages The combination of hands-on resources of a CRO supplemented with information from health-insurance claims allows for faster patient recruitment and more bang for the research buck. – Nancy A. Dreyer, MPH, Ph.D. Building bridges Th...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Michael J. Yanochik The Supreme Court’s First Word in the Latest Pricing Conflict In May 2003, the U.S. Supreme Court rendered a decision of significant interest to pharmaceutical manufacturers in Pharmaceutical Research and Mfrs. of Am. v. Walsh, 538 U.S. 644, 123 S.Ct. 1855 (2003...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Letter From The Editor Outcomes data can be used throughout an organization both vertically and horizontally and at various levels. But first, an organization must identify its definition of outcomes and how it will use the outcomes data. This definition will be driven by the organization’s inter...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
E-Media New Electronic and Web-based Applications, Sites, and Technologies Tripos Releases Desktop Development and Delivery Platform for 3-D Chemical Visualization Tripos Inc.’s LITHIUM 2.0 is a desktop development and delivery system for 3-D chemical visualization and decision support. Component...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma Trax Sales, marketing, And R&D Trends affecting the healthcare industry Medicare Reform to Result in More Use of Drugs As early as 2006, the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA) is expected to provide $10 billion to $15 billion in new drug spendin...
By PharmaVoice Team • Jan. 2, 2008
Previous
